Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

OEX_Yuanyuan_2303272232

ABSTRACT: untargeted lipidomics-neg

TISSUE(S): ['cell Line']

SUBMITTER: Yuanyuan Luo

PROVIDER: OEX00022971 | NODE | 2024-03-26

REPOSITORIES: NODE

ACCESS DATA

Json Xml

Similar Datasets

OEX_Yuanyuan_2303272229

Project description:untargeted metabolomics-neg

2024-03-26 | OEX00022969 | NODE

Mus musculus

Project description:Untargeted lipidomics and metagenomics reveal the mechanism of AEE relieving hyperlipidemia in ApoE-/- mice

| PRJNA1058527 | ENA

Genome-wide analysis of gene expression in human iPSCs and NSCs engineered by safe-harbor TALEN-mediated gene targeting

Project description:Human iPSCs and NSCs were engineered by AAVS1 and/or C13 safe-harbor TALENs which mediated targeted integration of various reporter genes at single or dual safe-harbor loci. Multiple clones of targeted human iPSCs were used to compare with parental untargeted NCRM5 iPSCs. Polyclonal targeted human NSCs were used to compare with their parental untargeted NCRM1NSCs or H9NSCs. Total RNA obtained from targeted human iPSCs or NSCs compared to untargeted control iPSCs or NSCs.

2014-09-01 | E-GEOD-55975 | biostudies-arrayexpress

OEX_Yuanyuan_2303272231

Project description:untargeted lipidomics-pos

2024-03-26 | OEX00022970 | NODE

Batch1 HILIC NEG untargeted metabolomics

Project description:Batch1 HILIC NEG untargeted metabolomics

2024-05-13 | OEX00027836 | NODE

Batch2 HILIC NEG untargeted metabolomics

Project description:Batch2 HILIC NEG untargeted metabolomics

2024-05-13 | OEX00027840 | NODE

Combination of Metabolomics, Lipidomics and Molecular Biology to Investigation of Metabolic Disturbance of Short-Term Administration of Emodin

Project description:To comprehensively elucidate the possible mechanism of short-term administration of emodin on the metabolic disturbance in vivo, our study utilized both LC/MS and NMR platforms for untargeted metabolomics studies. These analyses aimed to identify potential biomarkers associated with emodin-induced metabolic disturbances in mice. Subsequently, we delved into lipidomics to explore lipid metabolism systematically and determined the position of C=C double bonds in unsaturated lipids.

2024-10-17 | PXD055000 | Pride

Multiomics profiling of plasma reveals lipid-immune dysregulation and exosome remodeling in Mpox and Mpox-HIV co-infection 2

Project description:We performed integrated targeted lipidomics and untargeted metabolomics on patients' plasma (n = 81) from MPXV without HIV (MPLWOH), MPXV with HIV (MPLWH), HIV-positive without MPXV (PLWH) and healthy. Exosome proteomics and cytokine profiling complemented lipidome/metabolome analyses for functional interpretation.

2025-09-01 | PXD067934 |

Alzheimer’s disease-induced phagocytic microglia express a specific profile of coding and non-coding RNAs [short RNA]

Project description:To detect miRNAs in microglia derived from AD mice (5xFAD) brain we single cell sorted Cd11b+ and Cd45+ cells divided by Methoxy-X04 staining (Ab aggregates) positivity We performed differentially expression analysis of RNA-seq of wild-type microglia (Me-X04 neg), non-phagocytic AD microglia (Me-X04 neg), phagocytic AD microglia (Me-X04 positive)

2024-03-20 | GSE229417 | GEO

Lipidomic changes in persister cancer cells drive enhanced ferroptosis sensitivity

Project description:Persister cancer cells (PSs) are implicated in minimal residual disease from which cancer relapse occurs. PSs are sensitive to and present a critical point through which identification and targeting of PSs may be possible. To identify biomarkers for such cells, the drivers of ferroptosis sensitivity in PSs should be identified. Here, we first derived PSs from the lung carcinoma cell line PC9 (PSPC9), performed transcriptomic analysis, and observed enrichment of lipid and sugar metabolism gene expression in PSPC9. We performed untargeted and targeted lipidomics, revealing enrichment within PSPC9 for ferroptosis-driving diPUFA phospholipids (diPUFA-PL), as well as polyunsaturated free fatty acids (PUFA FFAs). Upon PSPC9 reversion to the ferroptosis-resistant parental state (PC9PS -> PC9), this lipid signature reverted. We generated two additional PS-like cell models: PS-like prostate carcinoma (PSLNCaP) from LNCaP and PS-like fibrosarcoma (PSHT1080) from HT1080. These PS-like models individually had features consistent with PS, including increased labile-iron pool, reversibility, and enhanced ferroptosis sensitivity. We performed lipidomics in these cell models, and identified lipid features consistent with those in PSPC9. Finally, we found that in PSHT1080, mitochondrial elimination partially abrogated ferroptosis sensitivity and altered the PSHT1080 lipid profile. In summary, we found that lipidomic changes dependent on the presence of mitochondria are key for the ferroptosis sensitivity of drug-tolerant persister cancer cells.

2025-12-31 | GSE300857 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data